The final phase of a clinical trial aiming to treat familial Alzheimer's disease using existing medication for Parkinson's ...

New study tests Parkinson’s drug to treat early-onset familial Alzheimer’s disease, a rare form of dementia, with results ...

Aroop Zutshi, Global Managing Partner and Executive Board Director of Frost & Sullivan, and Junyi Guo, General Manager of ...

They turn the food we eat into the energy our cells can use. But when stress hijacks the process they use to maintain their ...

Videos available at [ Key points A 94-year-old man with parkinsonism, followed in our geriatric medicine clinic, presented for routine follow-up, during which his wife reported that he had a ...

CBD, but not THC, may counteract the impact of a dysfunctional endogenous cannabinoid system in schizophrenia.

Mitochondria turn the food we eat into the energy our cells can use. But when stress hijacks the process they use to maintain ...

Muscimol, a GABA-A (GABAA) receptor agonist, enhances GABA's inhibitory effect on neuronal activity by activating GABAA ...

The novel PDE10A inhibitor CPL'36 offers a new mechanism of action and is both safe and effective for acute exacerbations of schizophrenia, new research suggests.

A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy being ...